News & Blog

Precision Medicine, Adaptive Clinical Trials, and Defeat GBM

President Barack Obama sent waves through the national news media when he announced during his 2015 State of the Union Address that he would be launching a “precision medicine” initiative. “Obama Proposes U.S. Spending to Research Personalized Cures,” was the headline from Bloomberg. “What is President Obama’s ‘precision medicine’ plan, and how might it help you?” asked […]

Defeat GBM Research Collaborative Produces Important Discovery

As we wrote on this blog back in May, the issue of “acquired resistance” is one of the biggest challenges in successfully treating brain tumors. Acquired resistance refers to tumor cells’ ability to learn to dodge the effects of treatment. Once a tumor develops resistance, current drugs stop working and the tumor can resume growing. […]

A Step Toward Identifying Risk Factors for Glioma

In 2007, the National Brain Tumor Society provided funding for an international project to search for more clues to one of the biggest mysteries of brain tumors – what causes them to develop. This week, researchers from this project, dubbed the Gliogene Consortium, published preliminary results from their study, which suggest rare mutations in a […]

Share